The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cells

Area of Science:

• Molecular Biology
• Oncology
• Cell Biology

Background:

• RhoE, an atypical Rho GTPase, may oppose RhoA's role in cell proliferation and invasion.
• Understanding RhoE's function in human cancer is crucial for developing new therapies.

Purpose of the Study:

• To investigate the expression patterns of RhoE in human cancer tissues.
• To determine the effects of RhoE expression on cancer cell malignant phenotypes.
• To explore the relationship between RhoE and p53 in cancer.

Main Methods:

• Immunocytochemistry to analyze RhoE expression in gastric, colorectal, lung, and breast carcinomas.
• Functional assays to assess the impact of enhanced RhoE expression on cancer cell proliferation, migration, invasion, and apoptosis.
• Luciferase assays to evaluate the effect of wild-type and mutant p53 on RhoE promoter activity.

Main Results:

• RhoE protein expression was significantly reduced in most examined cancer tissues compared to normal adjacent tissues.
• Increased RhoE expression inhibited proliferation, migration, and invasion, while inducing apoptosis in cancer cell lines with low endogenous RhoE.
• Wild-type p53 significantly upregulated RhoE expression and enhanced RhoE promoter activity, unlike mutant p53.

Conclusions:

• RhoE downregulation is implicated in human cancer progression.
• RhoE functions as a potential tumor suppressor and may be a target of p53.
• RhoE represents a promising candidate for cancer gene therapy.